Home/Filings/4/0001209191-23-037538
4//SEC Filing

WHITFIELD ROY A 4

Accession 0001209191-23-037538

CIK 0000906709other

Filed

Jun 14, 8:00 PM ET

Accepted

Jun 15, 6:26 PM ET

Size

6.7 KB

Accession

0001209191-23-037538

Insider Transaction Report

Form 4
Period: 2023-06-14
Transactions
  • Sale

    Common Stock

    2023-06-14$0.57/sh30,000$17,100216,250 total
Holdings
  • Common Stock

    (indirect: By Trust)
    51,500
  • Common Stock

    (indirect: By Trust)
    20,000
Footnotes (2)
  • [F1]This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  • [F2]This transaction was executed in multiple trades at prices ranging from $.57 to $.58. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.

Issuer

NEKTAR THERAPEUTICS

CIK 0000906709

Entity typeother

Related Parties

1
  • filerCIK 0000936728

Filing Metadata

Form type
4
Filed
Jun 14, 8:00 PM ET
Accepted
Jun 15, 6:26 PM ET
Size
6.7 KB